Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data

1 code implementation • 14 Mar 2023 • C. Wu, E. B. Gunnarsson, E. M. Myklebust, A. Köhn-Luque, D. S. Tadele, J. M. Enserink, A. Frigessi, J. Foo, K. Leder

Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies.